Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • daino3z
    Junior Member
    • Mar 2016
    • 1

    #1

    Examples of biological and maybe translational knowledge built with ChIP-seq?

    I am involved in the microfluidic implementation of ChIP-seq. Of course, I have general understanding of the basic questions that chip-seq can answer, i.e. genome-wide occupancy of a given protein. However, given the long trial-error loops and long time spent on methodological details, little time remains for me to address the question in the title thoroughly.

    Therefore I would like to ask you if you might be aware of notable examples in which ChIP-seq has actually been used not only to pinpoint protein occupancy genome-wide but also if this kind of information has been actually used to understand how genes are regulated by these proteins or, even better, if this information has been already translated to application like for example synthetic biology, genome engineering or even medicine.

    Thank you in advance for your time.

    What are the most notable examples of biological and maybe translational knowledge that has been built using ChIP-seq?
    Last edited by daino3z; 03-18-2016, 05:25 AM.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
60 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
75 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
74 views
0 reactions
Last Post SEQadmin2  
Working...